Can academic drug discovery programs improve on pharma’s relative stagnation?
Posted in Medicinal Plants, Pharmaceutical Biotechnology on Mar 31st, 2008
Terra Sigillata : Can academic drug discovery programs improve on pharma’s relative stagnation?
A paper in last month’s issue of Nature Reviews Drug Discovery reported that US drug approvals during 2007 were the lowest number since 1983. (17 new molecular entities and 2 biologicals; see this figure for 1996-2007 data.) The review cites increased regulatory action [...]